Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$858M |
| 2 |
Costco
COST
|
+$557M |
| 3 |
UnitedHealth
UNH
|
+$551M |
| 4 |
Atlassian
TEAM
|
+$489M |
| 5 |
Northrop Grumman
NOC
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nike
NKE
|
+$579M |
| 2 |
TSMC
TSM
|
+$433M |
| 3 |
Airbnb
ABNB
|
+$426M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$341M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$231M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.22% |
| 2 | Consumer Discretionary | 23.3% |
| 3 | Healthcare | 16.47% |
| 4 | Financials | 9.42% |
| 5 | Communication Services | 7.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DENN
476
DELISTED
Denny's
DENN
| $1.41M | ﹤0.01% |
150,072
+28,984
| +24% | +$278K |
|
477
Hilltop Holdings
HTH
$2.24B
| $1.39M | ﹤0.01% |
55,973
+11,020
| +25% | +$300K |
|
|
PCH
478
DELISTED
PotlatchDeltic
PCH
| $1.33M | ﹤0.01% |
32,497
+83
| +0.3% | +$3.81K |
|
479
W.W. Grainger
GWW
$60.2B
| $1.32M | ﹤0.01% |
2,707
+1,430
| +112% | +$753K |
|
480
Ball Corp
BALL
$16.8B
| $1.32M | ﹤0.01% |
+27,256
| New | +$1.68M |
|
481
Ulta Beauty
ULTA
$24.3B
| $1.29M | ﹤0.01% |
3,227
-11,754
| -78% | -$4.73M |
|
482
EXL Service
EXLS
$5.29B
| $1.28M | ﹤0.01% |
43,495
-560
| -1% | -$18.3K |
|
483
Adient
ADNT
$1.5B
| $1.28M | ﹤0.01% |
46,099
+12,466
| +37% | +$404K |
|
484
Korn Ferry
KFY
$4.28B
| $1.27M | ﹤0.01% |
27,023
+90
| +0.3% | +$5.32K |
|
485
Mueller Industries
MLI
$15.2B
| $1.27M | ﹤0.01% |
85,236
+16,260
| +24% | +$253K |
|
486
United Rentals
URI
$72.4B
| $1.25M | ﹤0.01% |
+4,613
| New | +$1.34M |
|
487
Adaptive Biotechnologies
ADPT
$3.97B
| $1.24M | ﹤0.01% |
+174,291
| New | +$1.64M |
|
488
Ziff Davis
ZD
$1.98B
| $1.2M | ﹤0.01% |
17,554
-224
| -1% | -$17.6K |
|
489
Vishay Intertechnology
VSH
$5.43B
| $1.18M | ﹤0.01% |
66,478
-36,058
| -35% | -$703K |
|
490
Option Care Health
OPCH
$3.56B
| $1.16M | ﹤0.01% |
36,865
+6,535
| +22% | +$209K |
|
|
AEL
491
DELISTED
American Equity Investment Life Holding Company
AEL
| $1.13M | ﹤0.01% |
30,320
+10,424
| +52% | +$391K |
|
492
Regenxbio
RGNX
$708M
| $1.12M | ﹤0.01% |
42,404
-3,164
| -7% | -$93.9K |
|
|
WIRE
493
DELISTED
Encore Wire Corp
WIRE
| $1.12M | ﹤0.01% |
9,685
-4,213
| -30% | -$513K |
|
494
Constellium
CSTM
$3.99B
| $1.11M | ﹤0.01% |
109,756
-540,468
| -83% | -$7.16M |
|
495
J.M. Smucker
SJM
$12.8B
| $1.11M | ﹤0.01% |
8,100
+2,338
| +41% | +$319K |
|
|
MDRX
496
DELISTED
Veradigm Inc. Common Stock
MDRX
| $1.09M | ﹤0.01% |
71,821
+26,332
| +58% | +$426K |
|
497
Innoviva
INVA
$1.48B
| $1.09M | ﹤0.01% |
94,153
+1,220
| +1% | +$16.7K |
|
498
RPC Inc
RES
$1.3B
| $1.06M | ﹤0.01% |
153,540
+1,252
| +0.8% | +$9.07K |
|
499
TriNet
TNET
$3.14B
| $1.06M | ﹤0.01% |
14,920
+1,023
| +7% | +$83.2K |
|
500
New Jersey Resources
NJR
$5.58B
| $1.05M | ﹤0.01% |
+27,057
| New | +$1.21M |
|
Similar funds
Jennison Associates's Q3 2022 Portfolio in Review
As of Q3 2022, Jennison Associates held 689 positions worth $101B, up 0.37% from $100B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Jennison Associates's Q3 2022 filing shows 75 new, 294 increased, 218 reduced and 90 closed positions. Its largest new stake was T-Mobile US: 1,657,443 shares worth $222M. The largest sale was Nike, an estimated $579M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Jennison Associates's largest Q3 2022 buy was T-Mobile US: 1,657,443 shares worth $222M.
- Jennison Associates added most to Vertex Pharmaceuticals in Q3 2022, an estimated $858M increase.
- Jennison Associates's biggest Q3 2022 reduction was Nike, cutting an estimated $579M.
- Jennison Associates fully exited Snap in Q3 2022, selling an estimated $197M.
- Jennison Associates's ten largest holdings make up 40% of its $101B portfolio in Q3 2022.
- Jennison Associates opened 75 new positions and closed 90 in Q3 2022.
- Jennison Associates's portfolio value rose 0.37% quarter-over-quarter to $101B.
Based on Jennison Associates's 13F filing for Q3 2022, filed 1 Nov 2022.